SNPsig® SARS-CoV-2 Real-Time PCR Mutation Detection/Allelic Discrimination Kits

​

• An alternative to next generation sequencing and S gene target failure (SGTF), it enables scientists to analyze and monitor these specific genomic mutations. 

• Pivotal in the role of screening for SARS-CoV-2 Variants for the purpose of genomic surveillance and studies.

​

Detection

Profile

• Assay SNPsig® SARS-CoV-2 (20I/501Y.V1) detects 20I/501Y.V1 (UK).

• Assay SNPsig® SARS-CoV-2 (20H/501Y.V2) detects 20H/501Y.V2 (SA).

• Assay SNPsig® SARS-CoV-2 (20J/501Y.V3) detects 20J/501Y.V3 (Brazil).

• Assay SNPsig® SARS-CoV-2 (N501Y) detects variants with the N501Y mutation (UK, SA and Brazil).

Important

Benefits

This assay offers the ability to track variants on-site and to generate a result in hours, compared to the current approach of next generation sequencing, which is typically constrained by limited capacity, cost and an offsite multi-day turnaround. This assay enables the identification of the non-variant virus and the UK, South Africa or Brazil variants, as well as any variant carrying the N501Y mutation.

KEY

Features

• Can be used as reflex testing as only extracted RNA is needed.

• Streamlined workflow for easy use with readily prepared master mix. 

• Open platform compatibility.

• No cold chain shipping. 

• 96 reactions per pack, with master mix included.

• This assay is one of the first commercially available for variant detection. 

ADDITIONAL COVID-19 TESTING PRODUCTS